Haiti

Haiti

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
1.62 (1.34 - 1.88) 2019 Modelled IHME
1.52 (1.25 - 1.76) 2018 Modelled IHME
1.49 (1.20 - 1.76) 2017 Modelled IHME
1.56 (1.28 - 1.82) 2016 Modelled IHME
1.66 (1.34 - 1.97) 2015 Modelled IHME
1.7 (1.38 - 2.03) 2014 Modelled IHME
1.74 (1.42 - 2.08) 2013 Modelled IHME
1.77 (1.45 - 2.11) 2012 Modelled IHME
1.8 (1.48 - 2.15) 2011 Modelled IHME
1.82 (1.49 - 2.18) 2010 Modelled IHME
1.85 (1.51 - 2.21) 2009 Modelled IHME
1.87 (1.54 - 2.22) 2008 Modelled IHME
1.89 (1.56 - 2.24) 2007 Modelled IHME
1.91 (1.56 - 2.27) 2006 Modelled IHME
1.92 (1.56 - 2.31) 2005 Modelled IHME
1.91 (1.55 - 2.28) 2004 Modelled IHME
1.89 (1.53 - 2.26) 2003 Modelled IHME
1.86 (1.49 - 2.23) 2002 Modelled IHME
1.84 (1.46 - 2.22) 2001 Modelled IHME
1.83 (1.44 - 2.24) 2000 Modelled IHME
1.84 (1.45 - 2.22) 1999 Modelled IHME
1.87 (1.48 - 2.23) 1998 Modelled IHME
1.89 (1.51 - 2.26) 1997 Modelled IHME
1.92 (1.54 - 2.28) 1996 Modelled IHME
1.93 (1.54 - 2.30) 1995 Modelled IHME
1.93 (1.55 - 2.29) 1994 Modelled IHME
1.92 (1.55 - 2.26) 1993 Modelled IHME
1.9 (1.55 - 2.24) 1992 Modelled IHME
1.88 (1.54 - 2.20) 1991 Modelled IHME
1.85 (1.52 - 2.16) 1990 Modelled IHME
3.07 (2.02 - 4.38) 2015 Modelled WHO
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
0.31 (0.23 - 0.41) 2019 Modelled IHME
0.31 (0.24 - 0.40) 2018 Modelled IHME
0.31 (0.23 - 0.40) 2017 Modelled IHME
0.31 (0.23 - 0.39) 2016 Modelled IHME
0.3 (0.22 - 0.40) 2015 Modelled IHME
0.39 (0.29 - 0.52) 2014 Modelled IHME
0.61 (0.46 - 0.82) 2013 Modelled IHME
0.87 (0.66 - 1.18) 2012 Modelled IHME
1.09 (0.82 - 1.49) 2011 Modelled IHME
1.21 (0.90 - 1.66) 2010 Modelled IHME
1.24 (0.94 - 1.64) 2009 Modelled IHME
1.26 (0.96 - 1.64) 2008 Modelled IHME
1.28 (0.98 - 1.64) 2007 Modelled IHME
1.29 (0.99 - 1.66) 2006 Modelled IHME
1.29 (0.99 - 1.69) 2005 Modelled IHME
1.28 (0.98 - 1.67) 2004 Modelled IHME
1.26 (0.95 - 1.64) 2003 Modelled IHME
1.24 (0.92 - 1.62) 2002 Modelled IHME
1.21 (0.88 - 1.61) 2001 Modelled IHME
1.2 (0.87 - 1.62) 2000 Modelled IHME
1.22 (0.88 - 1.61) 1999 Modelled IHME
1.25 (0.91 - 1.62) 1998 Modelled IHME
1.28 (0.95 - 1.67) 1997 Modelled IHME
1.31 (0.97 - 1.68) 1996 Modelled IHME
1.32 (0.97 - 1.74) 1995 Modelled IHME
1.32 (0.98 - 1.71) 1994 Modelled IHME
1.31 (0.99 - 1.68) 1993 Modelled IHME
1.3 (0.98 - 1.67) 1992 Modelled IHME
1.28 (0.97 - 1.63) 1991 Modelled IHME
1.25 (0.94 - 1.61) 1990 Modelled IHME
2.04 (1.26 - 3.10) 2015 Modelled WHO
Showing out of
Show more

HBV-related death rate

National
Download
Value (per 100,000) Year Type Source
3.02 (1.71 - 4.54) 2019 Modelled IHME
3 (1.69 - 4.51) 2018 Modelled IHME
2.99 (1.69 - 4.50) 2017 Modelled IHME
2.98 (1.68 - 4.46) 2016 Modelled IHME
2.97 (1.68 - 4.42) 2015 Modelled IHME
2.96 (1.68 - 4.42) 2014 Modelled IHME
2.94 (1.67 - 4.39) 2013 Modelled IHME
2.93 (1.66 - 4.31) 2012 Modelled IHME
2.95 (1.68 - 4.32) 2011 Modelled IHME
2.94 (1.72 - 4.29) 2010 Modelled IHME
2.98 (1.78 - 4.37) 2009 Modelled IHME
3 (1.79 - 4.34) 2008 Modelled IHME
3.03 (1.81 - 4.36) 2007 Modelled IHME
3.03 (1.82 - 4.42) 2006 Modelled IHME
3.05 (1.85 - 4.43) 2005 Modelled IHME
3.07 (1.86 - 4.42) 2004 Modelled IHME
3.07 (1.89 - 4.43) 2003 Modelled IHME
3.08 (1.92 - 4.43) 2002 Modelled IHME
3.12 (1.94 - 4.42) 2001 Modelled IHME
3.15 (1.95 - 4.42) 2000 Modelled IHME
3.22 (1.98 - 4.57) 1999 Modelled IHME
3.3 (2.01 - 4.65) 1998 Modelled IHME
3.48 (2.11 - 4.89) 1997 Modelled IHME
3.56 (2.15 - 5.01) 1996 Modelled IHME
3.7 (2.24 - 5.19) 1995 Modelled IHME
3.79 (2.28 - 5.34) 1994 Modelled IHME
3.88 (2.33 - 5.47) 1993 Modelled IHME
3.95 (2.38 - 5.60) 1992 Modelled IHME
3.98 (2.37 - 5.71) 1991 Modelled IHME
4.09 (2.43 - 5.92) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HBV-related deaths

National
Download
Value Year Type Source
374 (212 - 563) 2019 Modelled IHME
365 (206 - 549) 2018 Modelled IHME
356 (201 - 536) 2017 Modelled IHME
347 (197 - 520) 2016 Modelled IHME
339 (192 - 505) 2015 Modelled IHME
331 (188 - 494) 2014 Modelled IHME
321 (182 - 480) 2013 Modelled IHME
313 (178 - 461) 2012 Modelled IHME
308 (176 - 452) 2011 Modelled IHME
304 (177 - 443) 2010 Modelled IHME
304 (181 - 445) 2009 Modelled IHME
299 (178 - 432) 2008 Modelled IHME
294 (176 - 424) 2007 Modelled IHME
288 (172 - 419) 2006 Modelled IHME
283 (172 - 411) 2005 Modelled IHME
278 (169 - 400) 2004 Modelled IHME
271 (167 - 391) 2003 Modelled IHME
265 (166 - 381) 2002 Modelled IHME
262 (163 - 372) 2001 Modelled IHME
258 (160 - 363) 2000 Modelled IHME
257 (158 - 365) 1999 Modelled IHME
257 (157 - 362) 1998 Modelled IHME
265 (161 - 372) 1997 Modelled IHME
264 (159 - 371) 1996 Modelled IHME
268 (162 - 375) 1995 Modelled IHME
267 (160 - 377) 1994 Modelled IHME
267 (160 - 376) 1993 Modelled IHME
264 (159 - 374) 1992 Modelled IHME
259 (154 - 373) 1991 Modelled IHME
260 (155 - 376) 1990 Modelled IHME
754 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
31 (23 - 40) 2019 Modelled IHME
31 (23 - 40) 2018 Modelled IHME
31 (23 - 40) 2017 Modelled IHME
31 (23 - 40) 2016 Modelled IHME
30 (23 - 40) 2015 Modelled IHME
30 (23 - 40) 2014 Modelled IHME
30 (23 - 40) 2013 Modelled IHME
30 (23 - 40) 2012 Modelled IHME
30 (23 - 40) 2011 Modelled IHME
30 (22 - 40) 2010 Modelled IHME
30 (22 - 40) 2009 Modelled IHME
30 (22 - 39) 2008 Modelled IHME
30 (22 - 39) 2007 Modelled IHME
30 (22 - 39) 2006 Modelled IHME
30 (22 - 39) 2005 Modelled IHME
30 (22 - 39) 2004 Modelled IHME
30 (22 - 39) 2003 Modelled IHME
30 (22 - 39) 2002 Modelled IHME
30 (22 - 39) 2001 Modelled IHME
30 (22 - 39) 2000 Modelled IHME
30 (22 - 39) 1999 Modelled IHME
30 (22 - 39) 1998 Modelled IHME
30 (22 - 40) 1997 Modelled IHME
30 (22 - 40) 1996 Modelled IHME
30 (22 - 40) 1995 Modelled IHME
30 (22 - 40) 1994 Modelled IHME
30 (22 - 40) 1993 Modelled IHME
30 (22 - 40) 1992 Modelled IHME
30 (22 - 40) 1991 Modelled IHME
30 (22 - 40) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
64 2018 Survey/reported WHO/UNICEF
64 2017 Survey/reported WHO/UNICEF
64 2016 Survey/reported WHO/UNICEF
64 2015 Survey/reported WHO/UNICEF
63 2014 Survey/reported WHO/UNICEF
68 2013 Survey/reported WHO/UNICEF
Showing out of
Show more

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
0 (0 - 0) 2016 Survey/reported Harm Reduction International, 2016

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
0 2016 Survey/reported Harm Reduction International, 2016
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
No
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
No
At least one opioid substitution therapy (OST) program operational
No
NSP in at least one prison
No
OST in at least one prison
None

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
2.31 (1.84 - 2.91) 2019 Modelled IHME
2.31 (1.85 - 2.89) 2018 Modelled IHME
2.3 (1.85 - 2.91) 2017 Modelled IHME
2.3 (1.84 - 2.88) 2016 Modelled IHME
2.29 (1.83 - 2.88) 2015 Modelled IHME
2.29 (1.83 - 2.87) 2014 Modelled IHME
2.29 (1.84 - 2.88) 2013 Modelled IHME
2.3 (1.85 - 2.88) 2012 Modelled IHME
2.31 (1.84 - 2.88) 2011 Modelled IHME
2.31 (1.85 - 2.89) 2010 Modelled IHME
2.34 (1.88 - 2.88) 2009 Modelled IHME
2.38 (1.94 - 2.89) 2008 Modelled IHME
2.44 (2.02 - 2.92) 2007 Modelled IHME
2.49 (2.08 - 2.96) 2006 Modelled IHME
2.53 (2.11 - 2.98) 2005 Modelled IHME
2.54 (2.12 - 3) 2004 Modelled IHME
2.55 (2.13 - 3.01) 2003 Modelled IHME
2.56 (2.14 - 3.01) 2002 Modelled IHME
2.57 (2.15 - 3.03) 2001 Modelled IHME
2.58 (2.17 - 3.03) 2000 Modelled IHME
2.61 (2.19 - 3.05) 1999 Modelled IHME
2.63 (2.20 - 3.09) 1998 Modelled IHME
2.66 (2.23 - 3.13) 1997 Modelled IHME
2.69 (2.25 - 3.16) 1996 Modelled IHME
2.7 (2.25 - 3.19) 1995 Modelled IHME
2.7 (2.25 - 3.21) 1994 Modelled IHME
2.69 (2.24 - 3.22) 1993 Modelled IHME
2.68 (2.20 - 3.24) 1992 Modelled IHME
2.66 (2.15 - 3.26) 1991 Modelled IHME
2.63 (2.09 - 3.30) 1990 Modelled IHME
Showing out of
Show more

Prevalence of anti-HCV

National
Download
Value (%) Year Type Source
4.4 2004 Survey/reported Hepburn MJ et al, 2004

HCV-related death rate

National
Download
Value (per 100,000) Year Type Source
3.79 (1.91 - 5.85) 2019 Modelled IHME
3.79 (1.94 - 5.90) 2018 Modelled IHME
3.79 (1.94 - 5.77) 2017 Modelled IHME
3.77 (1.92 - 5.79) 2016 Modelled IHME
3.75 (1.93 - 5.80) 2015 Modelled IHME
3.74 (1.91 - 5.75) 2014 Modelled IHME
3.72 (1.90 - 5.69) 2013 Modelled IHME
3.71 (1.90 - 5.70) 2012 Modelled IHME
3.72 (1.89 - 5.66) 2011 Modelled IHME
3.74 (1.91 - 5.68) 2010 Modelled IHME
3.78 (1.93 - 5.66) 2009 Modelled IHME
3.82 (2 - 5.62) 2008 Modelled IHME
3.86 (2.03 - 5.62) 2007 Modelled IHME
3.87 (2.06 - 5.59) 2006 Modelled IHME
3.9 (2.10 - 5.61) 2005 Modelled IHME
3.92 (2.12 - 5.62) 2004 Modelled IHME
3.91 (2.07 - 5.61) 2003 Modelled IHME
3.92 (2.09 - 5.62) 2002 Modelled IHME
3.97 (2.12 - 5.69) 2001 Modelled IHME
3.99 (2.12 - 5.73) 2000 Modelled IHME
4.07 (2.16 - 5.78) 1999 Modelled IHME
4.15 (2.24 - 5.92) 1998 Modelled IHME
4.35 (2.33 - 6.23) 1997 Modelled IHME
4.44 (2.48 - 6.29) 1996 Modelled IHME
4.61 (2.53 - 6.61) 1995 Modelled IHME
4.72 (2.57 - 6.73) 1994 Modelled IHME
4.84 (2.65 - 6.84) 1993 Modelled IHME
4.94 (2.67 - 7.01) 1992 Modelled IHME
5 (2.67 - 7.07) 1991 Modelled IHME
5.18 (2.73 - 7.33) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HCV-related deaths

National
Download
Value Year Type Source
470 (237 - 726) 2019 Modelled IHME
461 (236 - 717) 2018 Modelled IHME
451 (231 - 687) 2017 Modelled IHME
439 (225 - 675) 2016 Modelled IHME
428 (220 - 663) 2015 Modelled IHME
418 (213 - 643) 2014 Modelled IHME
407 (207 - 622) 2013 Modelled IHME
397 (203 - 610) 2012 Modelled IHME
389 (197 - 592) 2011 Modelled IHME
386 (198 - 587) 2010 Modelled IHME
386 (197 - 577) 2009 Modelled IHME
381 (199 - 560) 2008 Modelled IHME
375 (198 - 547) 2007 Modelled IHME
368 (196 - 531) 2006 Modelled IHME
361 (195 - 520) 2005 Modelled IHME
355 (192 - 509) 2004 Modelled IHME
346 (183 - 496) 2003 Modelled IHME
338 (180 - 484) 2002 Modelled IHME
333 (178 - 478) 2001 Modelled IHME
327 (174 - 470) 2000 Modelled IHME
325 (173 - 462) 1999 Modelled IHME
323 (174 - 461) 1998 Modelled IHME
331 (178 - 474) 1997 Modelled IHME
329 (184 - 467) 1996 Modelled IHME
333 (183 - 478) 1995 Modelled IHME
332 (181 - 474) 1994 Modelled IHME
332 (182 - 469) 1993 Modelled IHME
330 (179 - 469) 1992 Modelled IHME
326 (174 - 461) 1991 Modelled IHME
329 (173 - 466) 1990 Modelled IHME
279 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
22 (15 - 30) 2019 Modelled IHME
22 (15 - 30) 2018 Modelled IHME
22 (15 - 30) 2017 Modelled IHME
22 (15 - 30) 2016 Modelled IHME
22 (15 - 30) 2015 Modelled IHME
22 (15 - 30) 2014 Modelled IHME
22 (15 - 30) 2013 Modelled IHME
22 (15 - 31) 2012 Modelled IHME
22 (15 - 30) 2011 Modelled IHME
23 (15 - 31) 2010 Modelled IHME
23 (15 - 31) 2009 Modelled IHME
23 (15 - 31) 2008 Modelled IHME
23 (15 - 31) 2007 Modelled IHME
23 (15 - 31) 2006 Modelled IHME
23 (15 - 31) 2005 Modelled IHME
23 (15 - 31) 2004 Modelled IHME
23 (15 - 31) 2003 Modelled IHME
23 (15 - 32) 2002 Modelled IHME
23 (15 - 32) 2001 Modelled IHME
23 (15 - 32) 2000 Modelled IHME
23 (15 - 32) 1999 Modelled IHME
23 (15 - 32) 1998 Modelled IHME
23 (15 - 32) 1997 Modelled IHME
23 (15 - 32) 1996 Modelled IHME
23 (15 - 32) 1995 Modelled IHME
23 (15 - 32) 1994 Modelled IHME
23 (15 - 31) 1993 Modelled IHME
23 (15 - 31) 1992 Modelled IHME
23 (15 - 31) 1991 Modelled IHME
23 (16 - 31) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
0 (0 - 0) 2016 Survey/reported Harm Reduction International, 2016

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
0 2016 Survey/reported Harm Reduction International, 2016
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
No
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
No
At least one opioid substitution therapy (OST) program operational
No
NSP in at least one prison
No
OST in at least one prison
None

Overview

HBV elimination goal
HCV elimination goal

Hepatitis related deaths (national)

Modelled

HBV
374
2019
(212 - 563)
IHME

Survey/surveillance

No data available
HBV chart

Modelled

HCV
470
2019
(237 - 726)
IHME

Survey/surveillance

No data available
HCV chart

Prevalence PWID

No data available

Birth dose vaccination coverage (national)

Survey/surveillance

No data available

No. of syringes/PWID/year

Survey/surveillance

HCV
0
2016
(0 - 0)
Harm Reduction International, 2016
Eligible for HBV generic medicines
Eligible for HCV generic medicines